Here Are the Key US-China Issues to Watch in Trump-Xi Summit

A meeting Thursday between Presidents Donald Trump and Xi Jinping is set to be one of the key diplomatic events of the year, with the US-China economic relationship at stake following multiple rounds of escalating tensions and temporary truces.

Trump told traveling reporters Monday on Air Force One that while nothing has yet been agreed, he felt good going into the meeting with Xi set to take place on the sidelines of the Asia-Pacific Economic Cooperation summit in South Korea.

US Treasury Secretary Scott Bessent, speaking in the same briefing, said a framework for Trump and Xi to finalize was forged over weekend talks with China, whose delegation was headed by Vice Premier He Lifeng.

The following are among the top issues the two sides have been haggling over:

Rare Earths

China’s curbs on exports of rare earths — a critical component in industrial supply chains, the processing of which is dominated by Chinese firms — has been a key pain point for the US this year. The Trump administration has sought to roll back more sweeping controls Beijing announced on Oct. 9, which were set to be implemented in December. Those require overseas firms to get Beijing’s approval for shipments of goods with even trace amounts of certain Chinese rare earths.

Bessent said Sunday he believed China would delay its latest rare-earth restrictions “for a year while they reexamine” the move.

Export Controls

The US has expanded its own export curbs this year, with Beijing in particular calling out a Sept. 29 move to vastly expand controls on the sale of semiconductor gear to subsidiaries of Chinese companies already on Washington’s so-called entity list. That step could affect thousands of China-linked enterprises around the world.

Bessent has said the framework he negotiated doesn’t involve the US rolling back its controls, though analysts suspect this indeed will be an area where China wins a quid-pro-quo concession.

Fentanyl Supply

Trump earlier this year slapped a 20% import surtax on Chinese goods over what he alleged was a failure by Beijing to curb exports of the drug fentanyl and its precursors. China’s Vice Commerce Minister Li Chenggang said over the weekend that a preliminary consensus had been reached on fentanyl, without offering details, raising the prospect of tariff relief.